𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma

✍ Scribed by F. Alongi; M. Bignardi; I. Garassino; S. Pentimalli; R. Cavina; P. Mancosu; G. Reggiori; A. Poletti; D. Ferrari; P. Foa; A. Bigoni; A. Dragonetti; P. Salvatori; O. Spahiu; A. Fogliata; L. Cozzi; A. Santoro; M. Scorsetti

Publisher
Springer
Year
2011
Tongue
German
Weight
419 KB
Volume
188
Category
Article
ISSN
0179-7158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Preoperative sequential chemotherapy in
Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck
✍ Sandrine Faivre; Adina Marti; Olivier Rixe; FranΓ§ois Janot; Morbize Julieron; Mi πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 2 views

## Abstract ## Background. Induction chemotherapy may contribute to decreased local and distant recurrences in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) resectable for cure. ## Methods. Patients with previously untreated locally advanced stage III–IV (N0

Phase II study of mitoxantrone in advanc
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck
✍ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap